{"url_path":"/sec/nmtc/10-q/2026/item-1","section_key":"item-1","section_title":"Item 1 Legal Proceedings**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-12","source_url":"https://www.sec.gov/Archives/edgar/data/1500198/0001213900-26-054749-index.html","accession_number":"0001213900-26-054749","cik":"0001500198","ticker":"NMTC","issuer_name":"NEUROONE MEDICAL TECHNOLOGIES Corp","edgar_url":"https://www.sec.gov/Archives/edgar/data/1500198/0001213900-26-054749-index.html","primary_entity_key":"0001500198","primary_entity_name":"NEUROONE MEDICAL TECHNOLOGIES Corp"},"word_count":78,"has_tables":true,"body_markdown":"**Item 1. Legal Proceedings**\n\n \n\nFrom time to time, we\nmay be involved in various claims and legal proceedings relating to claims arising out of our operations. We are not currently a party\nto any legal proceedings that, in the opinion of our management, are likely to have a material adverse effect on our business. Regardless\nof outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources and\nother factors."}